Dr. Rupak Kumar is a biomedical scientist and regulatory affairs professional whose expertise spans medical device evaluation, in-vitro diagnostics, and translational health technologies. As a Scientific Editor at Vigyaksha, he contributes his multidisciplinary experience to ensure regulatory clarity, scientific precision, and policy-driven editorial excellence.
He earned his Ph.D. in Biological Sciences from BITS Pilani, with a strong research foundation in bioanalytical techniques and molecular diagnostics. Post doctoral research at MGRI and SRI, Israel gives a foundation stone to address the environmental problem specific to pollutant removal through biological approaches. His career includes significant roles at premier institutions such as the Indian Council of Medical Research (ICMR) and the Central Drugs Standard Control Organization (CDSCO), where he led efforts in product evaluation, regulatory guidance, and policy implementation under India’s Medical Devices Rules, 2017. He holds specialized experience in ISO 13485 and the development of indigenous medical devices/IVD kits.
Dr. Kumar has also served as Research Fellow at NDTL, New Delhi and contributed to process and screen doping agent during various national and international sports events with Well versed in documentation as per ISO/IEC 17025:2005 and WADA-ISL (Ver. 6.0) guidelines.
In his role at Vigyaksha, Dr. Kumar focuses on enhancing editorial quality in articles related to Regulatory science and biomedical policy, Medical devices and IVD innovations, Public health and translational diagnostics.
With publications, patents, and years of mentorship experience, Dr. Kumar brings a regulatory lens and scientific rigor that strengthen Vigyaksha’s mission to bridge science, policy, and innovation. His dedication to enabling ethical, accessible healthcare technologies drives his editorial vision.
